Acute pulmonary embolism in COVID-19 related hypercoagulability

Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromb...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of thrombosis and thrombolysis Ročník 50; číslo 1; s. 223 - 226
Hlavní autori: Lorenzo, Cerruti, Francesca, Boscaro, Francesco, Poletto, Elena, Campello, Luca, Spiezia, Paolo, Simioni
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Springer US 01.07.2020
Springer Nature B.V
Predmet:
ISSN:0929-5305, 1573-742X, 1573-742X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0929-5305
1573-742X
1573-742X
DOI:10.1007/s11239-020-02160-1